Concepedia

Yoshiteru Kamiyama

YK

Statistics

Publications

8

Citations

355

H-Index

8

Active since

2001

Affiliations

Astellas Pharma (Japan)(Current)

Tohoku University

Tohoku Medical and Pharmaceutical University

Yoshiteru Kamiyama is an author at Astellas Pharma (Japan) specializing in pharmacology, life sciences, and metabolism.

Publications per year

2001–2019

8

Publications

8

Role of Human Hepatocyte Nuclear Factor 4α in the Expression of Drug-Metabolizing Enzymes and Transporters in Human Hepatocytes Assessed by Use of Small Interfering RNA

Yoshiteru Kamiyama, Tsutomu Matsubara, Kouichi Yoshinari et al. · Drug Metabolism and Pharmacokinetics · 2007 · 133 citations

, , +17

In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)

Aya Kikuchi, Takashi Furutani, Hidenori Azami et al. · Investigational New Drugs · 2014 · 59 citations

, , +7

Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms.

Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari et al. · PubMed · 2001 · 47 citations

, , +9

Analysis of the impact of controlled release formulations on oral drug absorption, gut wall metabolism and relative bioavailability of CYP3A substrates using a physiologically-based pharmacokinetic model

Andrés Olivares‐Morales, Yoshiteru Kamiyama, Adam S. Darwich et al. · European Journal of Pharmaceutical Sciences · 2014 · 40 citations · Full text

, , +16

Unique Properties of a Renal Sulfotransferase, St1d1, in Dopamine Metabolism

Miki Shimada, Reiko Terazawa, Yoshiteru Kamiyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 24 citations

, , +13

1–5 of 8